Sanjana Ballal

2.7k total citations
88 papers, 1.9k citations indexed

About

Sanjana Ballal is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sanjana Ballal has authored 88 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Radiology, Nuclear Medicine and Imaging, 40 papers in Oncology and 30 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sanjana Ballal's work include Radiopharmaceutical Chemistry and Applications (38 papers), Thyroid Cancer Diagnosis and Treatment (27 papers) and Peptidase Inhibition and Analysis (22 papers). Sanjana Ballal is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (38 papers), Thyroid Cancer Diagnosis and Treatment (27 papers) and Peptidase Inhibition and Analysis (22 papers). Sanjana Ballal collaborates with scholars based in India, Germany and United States. Sanjana Ballal's co-authors include Madhav Prasad Yadav, Chandrasekhar Bal, Ranjit Kumar Sahoo, Madhavi Tripathi, Chandrasekhar Bal, Frank Roesch, Euy Sung Moon, Amlesh Seth, Vasko Kramer and Sreedharan Thankarajan Arunraj and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Sanjana Ballal

82 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sanjana Ballal India	24	1.1k	976	692	412	397	88	1.9k
Madhav Prasad Yadav India	22	1.1k 1.0×	963 1.0×	677 1.0×	334 0.8×	371 0.9×	59	1.8k
Jolanta Kunikowska Poland	23	914 0.8×	728 0.7×	510 0.7×	219 0.5×	736 1.9×	96	2.0k
Inga Buchmann Germany	20	788 0.7×	507 0.5×	376 0.5×	305 0.7×	461 1.2×	49	1.8k
James Nagarajah Germany	29	1.2k 1.1×	621 0.6×	856 1.2×	290 0.7×	277 0.7×	121	2.3k
Aviral Singh Germany	27	1.4k 1.3×	1.2k 1.3×	1.1k 1.5×	168 0.4×	788 2.0×	62	2.3k
Andrei Todica Germany	21	840 0.7×	384 0.4×	460 0.7×	196 0.5×	243 0.6×	105	1.5k
Christian Uprimny Austria	24	1.3k 1.2×	1.3k 1.3×	1.3k 1.8×	379 0.9×	1.3k 3.3×	73	3.1k
Christiane Schuchardt Germany	18	1.3k 1.2×	867 0.9×	877 1.3×	129 0.3×	379 1.0×	42	1.8k
Tim J. Kruser United States	23	420 0.4×	894 0.9×	898 1.3×	292 0.7×	568 1.4×	76	2.2k
Hans‐Juergen Wester Germany	22	1.1k 0.9×	716 0.7×	864 1.2×	223 0.5×	186 0.5×	38	2.0k

Countries citing papers authored by Sanjana Ballal

Since Specialization

Citations

This map shows the geographic impact of Sanjana Ballal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjana Ballal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjana Ballal more than expected).

Fields of papers citing papers by Sanjana Ballal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjana Ballal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjana Ballal. The network helps show where Sanjana Ballal may publish in the future.

Co-authorship network of co-authors of Sanjana Ballal

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjana Ballal. A scholar is included among the top collaborators of Sanjana Ballal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjana Ballal. Sanjana Ballal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ballal, Sanjana, Chandrasekhar Bal, Tilman Läppchen, et al.. (2025). Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation study. European Journal of Nuclear Medicine and Molecular Imaging. 52(9). 3238–3251. 5 indexed citations

Ballal, Sanjana, Madhav Prasad Yadav, Swayamjeet Satapathy, et al.. (2025). Long-Term Outcomes in Radioiodine-Resistant Follicular Cell-Derived Thyroid Cancers Treated with [ ¹⁷⁷ Lu]Lu-DOTAGA.FAPi Dimer Therapy. Thyroid. 35(2). 188–198. 6 indexed citations

Satapathy, Swayamjeet, et al.. (2024). Plasma cell-free DNA as predictor of disease status in patients with differentiated thyroid cancer - a prospective study from a tertiary care institution. Frontiers in Oncology. 14. 1473262–1473262.

Ballal, Sanjana, Madhav Prasad Yadav, Frank Roesch, et al.. (2024). Head-to-Head Comparison of SSTR Antagonist [68Ga]Ga-DATA5m-LM4 with SSTR Agonist [68Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study. Pharmaceuticals. 17(3). 275–275. 6 indexed citations

Ballal, Sanjana, Madhav Prasad Yadav, Frank Roesch, et al.. (2023). Head-to-Head Comparison of [ ⁶⁸ Ga]Ga-DOTA.SA.FAPi and [ ⁶⁸ Ga]Ga-DOTANOC Positron Emission Tomography/Computed Tomography Imaging for the Follow-Up Surveillance of Patients with Medullary Thyroid Cancer. Thyroid. 33(8). 974–982. 15 indexed citations

Yadav, Madhav Prasad, et al.. (2023). Complete Response to 177Lu-DOTATATE PRRT in a 9-Year-Old Child With Metastatic Carotid Body Paraganglioma. Clinical Nuclear Medicine. 49(1). e33–e34. 4 indexed citations

Satapathy, Swayamjeet, et al.. (2023). Appropriateness of 14‐year cutoff in pediatric differentiated thyroid cancer: Comparison of clinical characteristics and long‐term outcomes in 14 years and younger and 15–18 years age groups. Pediatric Blood & Cancer. 70(10). e30596–e30596.

Satapathy, Swayamjeet, et al.. (2023). Radioiodine versus no radioiodine outcomes in low‐risk differentiated thyroid cancers: A propensity‐score matched analysis. Clinical Endocrinology. 99(5). 483–491. 5 indexed citations

Ballal, Sanjana, Madhav Prasad Yadav, Frank Roesch, et al.. (2023). Head-to-Head Comparison between [68Ga]Ga-DOTA.SA.FAPi and [18F]F-FDG PET/CT Imaging in Patients with Breast Cancer. Pharmaceuticals. 16(4). 521–521. 14 indexed citations

10.

Ballal, Sanjana, Madhav Prasad Yadav, Euy Sung Moon, et al.. (2021). First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2. Pharmaceuticals. 14(12). 1212–1212. 93 indexed citations

11.

Ballal, Sanjana, Madhav Prasad Yadav, Vasko Kramer, et al.. (2020). A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging. 48(3). 942–944. 105 indexed citations

12.

Ballal, Sanjana, Madhav Prasad Yadav, Euy Sung Moon, et al.. (2020). Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers. European Journal of Nuclear Medicine and Molecular Imaging. 48(6). 1915–1931. 111 indexed citations

13.

Yadav, Madhav Prasad, Sanjana Ballal, Ranjit Kumar Sahoo, et al.. (2020). Efficacy and safety of ²²⁵Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients. Theranostics. 10(20). 9364–9377. 107 indexed citations

14.

Bal, Chandrasekhar, Madhav Prasad Yadav, Sanjana Ballal, & Madhavi Tripathi. (2020). Safety and Therapeutic Efficacy of 225Ac-DOTATATE Targeted Alpha Therapy in Metastatic Gastroenteropancreatic Neuroendocrine Tumors Stable or Refractory to 177Lu-DOTATATE PRRT. 61. 416–416. 4 indexed citations

15.

Bal, Chandrasekhar, et al.. (2019). Long-term clinicopathological features of a family with multiple endocrine neoplasia type 2A caused by C634R RET gene mutation. Indian Journal of Nuclear Medicine. 35(1). 48–48.

16.

Bal, Chandrasekhar, et al.. (2019). Coexistence of multiple metastatic lesions showing various grades of differentiation in a single patient with neuroendocrine tumor of lung as primary: A combined modality approach of ⁶⁸ Ga-DOTANOC positron emission tomography/computed tomography and ¹⁸ F-fluorodeoxyglucose positron emission tomography/computed tomography imaging. Indian Journal of Nuclear Medicine. 34(3). 260–260. 3 indexed citations

17.

Ballal, Sanjana, Madhav Prasad Yadav, Chandrasekhar Bal, Ranjit Kumar Sahoo, & Madhavi Tripathi. (2019). Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety. European Journal of Nuclear Medicine and Molecular Imaging. 47(4). 934–946. 144 indexed citations

18.

Arora, Saurabh, et al.. (2018). Clinical issues related to fluid management during ¹⁷⁷ Lu-peptide receptor radionuclide therapy in metastatic neuroendocrine tumors with carcinoid heart disease. Indian Journal of Nuclear Medicine. 33(4). 359–359.

19.

Guleria, Prerna, Shipra Agarwal, Deepali Jain, et al.. (2018). Cytopathology of Solid Variant of Papillary Thyroid Carcinoma: Differential Diagnoses with other Thyroid Tumors. Acta Cytologica. 62(5-6). 371–379. 7 indexed citations

20.

Arora, Geetanjali, Rajesh Mishra, Praveen Kumar, et al.. (2017). Estimation of whole body radiation exposure to nuclear medicine personnel during synthesis of ¹⁷⁷ lutetium-labeled radiopharmaceuticals. Indian Journal of Nuclear Medicine. 32(2). 89–89. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact